Rallis India has announced its financial results for the second quarter and half year ended September 30, 2026. For the half year, revenue increased by 3% to ₹1,880 crore, while Profit After Tax (PAT) grew by 6% to ₹210 crore. The company navigated a challenging operating environment, focusing on portfolio and operational efficiencies.
Rallis India Reports Q2 and H1 FY27 Financial Performance
Mumbai, October 22, 2026 – Rallis India Limited, a key player in the Indian agri-inputs industry, today announced its financial results for the second quarter (Q2) and the first half year (H1) ended September 30, 2026. The company reported a resilient performance amidst a disruptive business environment, driven by a focus on portfolio and operational efficiencies.
Half-Year Financial Highlights (H1 FY27)
For the half year ended September 2026, Rallis reported a total revenue of ₹1,880 crore, an increase of 3% compared to ₹1,818 crore in H1 FY26. Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) stood at ₹311 crore, up from ₹304 crore in the previous year. Profit After Tax (PAT) for the period grew by 6% to ₹210 crore, compared to ₹197 crore in H1 FY26. The company’s EBITDA margin for H1 FY27 was 16.5%, with a PAT margin of 11.2%.
Quarterly Performance (Q2 FY27)
In the second quarter of FY27, Rallis India recorded revenue of ₹858 crore, slightly down from ₹861 crore in the corresponding quarter of the previous year. PAT for Q2 FY27 was ₹85 crore, a decrease from ₹102 crore in Q2 FY26. EBITDA for the quarter was reported at ₹126 crore, compared to ₹154 crore in the prior-year period. The company’s EBITDA margin for Q2 FY27 stood at 14.7%, with a PAT margin of 9.9%.
Business Segment Performance
The Crop Care business demonstrated topline growth of 4%, primarily fueled by a 17% increase in the B2B segment, attributed to a strong recovery in the CSM portfolio. Domestic Formulations (B2C) remained flat year-on-year, with herbicides showing a 16% growth, while insecticides saw flat performance. The Soil & Plant Health (SPH) business recorded a significant 22% growth, largely driven by price increases.
During the quarter, Rallis launched four new products within the Crop Care category: Silentra (Insecticide), Marcellus (Fungicide), Blitox Super (Fungicide), and Trynage (Herbicide). These products are designed to address critical crop-pest segments, including Rice BPH and sheath blight, sugarcane herbicides, and disease control in horticulture crops.
The Seeds business experienced a decline, which the company attributes primarily to higher returns from the Kharif season.
Management Commentary
Dr. Gyanendra Shukla, Managing Director & CEO of Rallis India Limited, commented, “Rallis navigated a disruptive business environment during Q2 FY27 by focussing on portfolio and operational efficiencies.” He also noted that weather-related disruptions and delayed sowing continued to impact market demand during the quarter/season. The company remains focused on improving market execution, driving cost efficiencies, and strengthening customer engagement to navigate these challenges and enhance business performance.
Source: BSE
